View in EDS HTML Full Text PDF Full Text

Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis.

Saved in:
Bibliographic Details
Title: Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis.
Authors: Bastacky ML; Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, PA, United States., Wang H; Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States., Fortman D; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States., Rahman Z; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States., Mascara GP; Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, PA, United States., Brenner T; Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, PA, United States., Najjar YG; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States., Luke JJ; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States., Kirkwood JM; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States., Zarour HM; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States., Davar D; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States.
Source: Frontiers in oncology [Front Oncol] 2021 Nov 26; Vol. 11, pp. 749064. Date of Electronic Publication: 2021 Nov 26 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34900695
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bastacky+ML%22">Bastacky ML</searchLink>; Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Fortman+D%22">Fortman D</searchLink>; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Rahman+Z%22">Rahman Z</searchLink>; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Mascara+GP%22">Mascara GP</searchLink>; Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Brenner+T%22">Brenner T</searchLink>; Department of Pharmacy, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Najjar+YG%22">Najjar YG</searchLink>; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Luke+JJ%22">Luke JJ</searchLink>; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Kirkwood+JM%22">Kirkwood JM</searchLink>; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Zarour+HM%22">Zarour HM</searchLink>; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States.<br /><searchLink fieldCode="AU" term="%22Davar+D%22">Davar D</searchLink>; Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, United States.; University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh, PA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2021 Nov 26; Vol. 11, pp. 749064. <i>Date of Electronic Publication: </i>2021 Nov 26 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34900695
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2021.749064
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 749064
    Titles:
      – TitleFull: Immune-Related Adverse Events in PD-1 Treated Melanoma and Impact Upon Anti-Tumor Efficacy: A Real World Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bastacky ML
      – PersonEntity:
          Name:
            NameFull: Wang H
      – PersonEntity:
          Name:
            NameFull: Fortman D
      – PersonEntity:
          Name:
            NameFull: Rahman Z
      – PersonEntity:
          Name:
            NameFull: Mascara GP
      – PersonEntity:
          Name:
            NameFull: Brenner T
      – PersonEntity:
          Name:
            NameFull: Najjar YG
      – PersonEntity:
          Name:
            NameFull: Luke JJ
      – PersonEntity:
          Name:
            NameFull: Kirkwood JM
      – PersonEntity:
          Name:
            NameFull: Zarour HM
      – PersonEntity:
          Name:
            NameFull: Davar D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 11
              Text: 2021 Nov 26
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1